Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
2.970
-0.140 (-4.50%)
At close: Feb 20, 2026, 4:00 PM EST
2.980
+0.010 (0.34%)
After-hours: Feb 20, 2026, 7:19 PM EST
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $254.2 million as of February 20, 2026. Its market cap has increased by 4.29% in one year.
Market Cap
254.20M
Enterprise Value
83.12M
1-Year Change
4.29%
Ranking
Category
Stock Price
$2.97
Market Cap Chart
Since May 29, 2020, Larimar Therapeutics's market cap has increased from $113.38M to $254.20M, an increase of 124.20%. That is a compound annual growth rate of 15.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 254.20M | -22.05% |
| Dec 31, 2025 | 326.10M | 32.06% |
| Dec 31, 2024 | 246.93M | 23.61% |
| Dec 29, 2023 | 199.77M | 11.79% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Climb Bio | 268.80M |
| Aardvark Therapeutics | 268.25M |
| Avalo Therapeutics | 263.07M |
| Shattuck Labs | 253.75M |
| AC Immune | 249.34M |
| Protalix BioTherapeutics | 246.09M |
| OmniAb | 244.72M |
| Coherus Oncology | 243.64M |